Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Multiple Sclerosis Therapies
1.2 Key Market Segments
1.2.1 Multiple Sclerosis Therapies Segment by Type
1.2.2 Multiple Sclerosis Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Multiple Sclerosis Therapies Market Overview
2.1 Global Market Overview
2.1.1 Global Multiple Sclerosis Therapies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Multiple Sclerosis Therapies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Multiple Sclerosis Therapies Market Competitive Landscape
3.1 Global Multiple Sclerosis Therapies Sales by Manufacturers (2019-2024)
3.2 Global Multiple Sclerosis Therapies Revenue Market Share by Manufacturers (2019-2024)
3.3 Multiple Sclerosis Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Multiple Sclerosis Therapies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Multiple Sclerosis Therapies Sales Sites, Area Served, Product Type
3.6 Multiple Sclerosis Therapies Market Competitive Situation and Trends
3.6.1 Multiple Sclerosis Therapies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Multiple Sclerosis Therapies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Multiple Sclerosis Therapies Industry Chain Analysis
4.1 Multiple Sclerosis Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Multiple Sclerosis Therapies Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Multiple Sclerosis Therapies Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Multiple Sclerosis Therapies Sales Market Share by Type (2019-2024)
6.3 Global Multiple Sclerosis Therapies Market Size Market Share by Type (2019-2024)
6.4 Global Multiple Sclerosis Therapies Price by Type (2019-2024)
7 Multiple Sclerosis Therapies Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Multiple Sclerosis Therapies Market Sales by Application (2019-2024)
7.3 Global Multiple Sclerosis Therapies Market Size (M USD) by Application (2019-2024)
7.4 Global Multiple Sclerosis Therapies Sales Growth Rate by Application (2019-2024)
8 Multiple Sclerosis Therapies Market Segmentation by Region
8.1 Global Multiple Sclerosis Therapies Sales by Region
8.1.1 Global Multiple Sclerosis Therapies Sales by Region
8.1.2 Global Multiple Sclerosis Therapies Sales Market Share by Region
8.2 North America
8.2.1 North America Multiple Sclerosis Therapies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Multiple Sclerosis Therapies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Multiple Sclerosis Therapies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Multiple Sclerosis Therapies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Multiple Sclerosis Therapies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bayer
9.1.1 Bayer Multiple Sclerosis Therapies Basic Information
9.1.2 Bayer Multiple Sclerosis Therapies Product Overview
9.1.3 Bayer Multiple Sclerosis Therapies Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Multiple Sclerosis Therapies SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Biogen
9.2.1 Biogen Multiple Sclerosis Therapies Basic Information
9.2.2 Biogen Multiple Sclerosis Therapies Product Overview
9.2.3 Biogen Multiple Sclerosis Therapies Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Multiple Sclerosis Therapies SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Bristol Myers Squibb
9.3.1 Bristol Myers Squibb Multiple Sclerosis Therapies Basic Information
9.3.2 Bristol Myers Squibb Multiple Sclerosis Therapies Product Overview
9.3.3 Bristol Myers Squibb Multiple Sclerosis Therapies Product Market Performance
9.3.4 Bristol Myers Squibb Multiple Sclerosis Therapies SWOT Analysis
9.3.5 Bristol Myers Squibb Business Overview
9.3.6 Bristol Myers Squibb Recent Developments
9.4 Roche
9.4.1 Roche Multiple Sclerosis Therapies Basic Information
9.4.2 Roche Multiple Sclerosis Therapies Product Overview
9.4.3 Roche Multiple Sclerosis Therapies Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 GSK
9.5.1 GSK Multiple Sclerosis Therapies Basic Information
9.5.2 GSK Multiple Sclerosis Therapies Product Overview
9.5.3 GSK Multiple Sclerosis Therapies Product Market Performance
9.5.4 GSK Business Overview
9.5.5 GSK Recent Developments
9.6 Merck Group
9.6.1 Merck Group Multiple Sclerosis Therapies Basic Information
9.6.2 Merck Group Multiple Sclerosis Therapies Product Overview
9.6.3 Merck Group Multiple Sclerosis Therapies Product Market Performance
9.6.4 Merck Group Business Overview
9.6.5 Merck Group Recent Developments
9.7 Novartis
9.7.1 Novartis Multiple Sclerosis Therapies Basic Information
9.7.2 Novartis Multiple Sclerosis Therapies Product Overview
9.7.3 Novartis Multiple Sclerosis Therapies Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Teva Pharmaceutical Industries
9.8.1 Teva Pharmaceutical Industries Multiple Sclerosis Therapies Basic Information
9.8.2 Teva Pharmaceutical Industries Multiple Sclerosis Therapies Product Overview
9.8.3 Teva Pharmaceutical Industries Multiple Sclerosis Therapies Product Market Performance
9.8.4 Teva Pharmaceutical Industries Business Overview
9.8.5 Teva Pharmaceutical Industries Recent Developments
9.9 Sanofi
9.9.1 Sanofi Multiple Sclerosis Therapies Basic Information
9.9.2 Sanofi Multiple Sclerosis Therapies Product Overview
9.9.3 Sanofi Multiple Sclerosis Therapies Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
10 Multiple Sclerosis Therapies Market Forecast by Region
10.1 Global Multiple Sclerosis Therapies Market Size Forecast
10.2 Global Multiple Sclerosis Therapies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Multiple Sclerosis Therapies Market Size Forecast by Country
10.2.3 Asia Pacific Multiple Sclerosis Therapies Market Size Forecast by Region
10.2.4 South America Multiple Sclerosis Therapies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Multiple Sclerosis Therapies by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Multiple Sclerosis Therapies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Multiple Sclerosis Therapies by Type (2025-2030)
11.1.2 Global Multiple Sclerosis Therapies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Multiple Sclerosis Therapies by Type (2025-2030)
11.2 Global Multiple Sclerosis Therapies Market Forecast by Application (2025-2030)
11.2.1 Global Multiple Sclerosis Therapies Sales (K Units) Forecast by Application
11.2.2 Global Multiple Sclerosis Therapies Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings